Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations

P. Baird, R. Wadey, John Kenneth Cowell

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Although a candidate Wilms' tumour gene-WT1-has been identified in chromosome region 11p13, there is strong evidence from loss of heterozygosity studies suggesting that a second relevant gene is present in region 11p15. The Harvey-Ras proto-oncogene also lies in this region. In other types of tumours mutations in RAS genes have been associated with the development and/or progression of a number of tumour types. We therefore analysed the sequence of the Ras oncogene for possible mutations in six Wilms' tumours showing loss of heterozygosity for chromosome region 11p15. No tumour analysed showed HRAS sequence mutations. We conclude that loss of heterozygosity at 11p15 does not implicate HRAS mutations in the molecular pathogenesis of Wilms' tumour.

Original languageEnglish (US)
Pages (from-to)1147-1149
Number of pages3
JournalOncogene
Volume6
Issue number7
StatePublished - Sep 6 1991
Externally publishedYes

Fingerprint

Wilms Tumor
Loss of Heterozygosity
Oncogenes
Chromosomes
Mutation
ras Genes
Wilms' Tumor Genes
Neoplasms
Proto-Oncogenes
Genes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations. / Baird, P.; Wadey, R.; Cowell, John Kenneth.

In: Oncogene, Vol. 6, No. 7, 06.09.1991, p. 1147-1149.

Research output: Contribution to journalArticle

@article{1be60028bffd4e13bf47bee6049f849f,
title = "Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations",
abstract = "Although a candidate Wilms' tumour gene-WT1-has been identified in chromosome region 11p13, there is strong evidence from loss of heterozygosity studies suggesting that a second relevant gene is present in region 11p15. The Harvey-Ras proto-oncogene also lies in this region. In other types of tumours mutations in RAS genes have been associated with the development and/or progression of a number of tumour types. We therefore analysed the sequence of the Ras oncogene for possible mutations in six Wilms' tumours showing loss of heterozygosity for chromosome region 11p15. No tumour analysed showed HRAS sequence mutations. We conclude that loss of heterozygosity at 11p15 does not implicate HRAS mutations in the molecular pathogenesis of Wilms' tumour.",
author = "P. Baird and R. Wadey and Cowell, {John Kenneth}",
year = "1991",
month = "9",
day = "6",
language = "English (US)",
volume = "6",
pages = "1147--1149",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations

AU - Baird, P.

AU - Wadey, R.

AU - Cowell, John Kenneth

PY - 1991/9/6

Y1 - 1991/9/6

N2 - Although a candidate Wilms' tumour gene-WT1-has been identified in chromosome region 11p13, there is strong evidence from loss of heterozygosity studies suggesting that a second relevant gene is present in region 11p15. The Harvey-Ras proto-oncogene also lies in this region. In other types of tumours mutations in RAS genes have been associated with the development and/or progression of a number of tumour types. We therefore analysed the sequence of the Ras oncogene for possible mutations in six Wilms' tumours showing loss of heterozygosity for chromosome region 11p15. No tumour analysed showed HRAS sequence mutations. We conclude that loss of heterozygosity at 11p15 does not implicate HRAS mutations in the molecular pathogenesis of Wilms' tumour.

AB - Although a candidate Wilms' tumour gene-WT1-has been identified in chromosome region 11p13, there is strong evidence from loss of heterozygosity studies suggesting that a second relevant gene is present in region 11p15. The Harvey-Ras proto-oncogene also lies in this region. In other types of tumours mutations in RAS genes have been associated with the development and/or progression of a number of tumour types. We therefore analysed the sequence of the Ras oncogene for possible mutations in six Wilms' tumours showing loss of heterozygosity for chromosome region 11p15. No tumour analysed showed HRAS sequence mutations. We conclude that loss of heterozygosity at 11p15 does not implicate HRAS mutations in the molecular pathogenesis of Wilms' tumour.

UR - http://www.scopus.com/inward/record.url?scp=0025789048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025789048&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 1147

EP - 1149

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 7

ER -